Sustainability & Climate

A new 40-unit housing project in Barrie offers an intensive, data-driven approach to help the unsheltered. Can this pilot become a national solution?

Chinese brand CHANDO presented a decade of research at IMCAS, revealing a new epigenetic mechanism that could revolutionize brightening for Asian skin.

After winning a major award, OnMed's tech-enabled CareStation promises to revolutionize access to care. But can this hybrid model solve a national crisis?

AtlasFX's award-winning BankMinder brings data-driven transparency to FX risk, promising to slash hidden costs and empower corporate treasurers.

A new federal grant positions Curio's NuCycle technology to tackle nuclear waste, promising a cleaner, more sustainable American energy future.

As Timbercreek Financial preps its Q4 report, investors eye dividend health and asset quality as key indicators for the broader CRE market's new cycle.

Major brands and tech firm Rokt join the AHA's new initiative, using AI and the power of retail to fight the leading cause of death among women.

Horizon Media's new HorizonOS integrates Intent IQ's identity tech to unlock valuable, hard-to-reach audiences on iOS, CTV, and cookieless browsers.

The high-tech wheel maker's stock plummets 65% as it fails to meet listing rules, signaling deep financial and operational distress for the company.

A small-cap food company plans a major NASDAQ leap, but its future hinges on a secret 'clean' technology. Can this ambitious, risky pivot succeed?

Ernexa Therapeutics secures crucial funding for its cancer therapy pipeline, but the dilutive offering sends its stock plunging more than 50%.

Strong investor demand boosts financing for BC's Golden Triangle exploration, highlighting Canada's strategic push into the critical minerals sector.

Upexi's new funding bolsters its ambitious Solana treasury, but the deal's terms, including warrant adjustments, raise dilution concerns for investors.

CR Fitness Holdings announces a 43,000 sq ft Crunch gym in Maitland, signaling a major move in Central Florida's competitive fitness market.

Australian biotech Immutep reaches a key milestone in its Phase III trial for a novel lung cancer therapy, a major step in a multi-billion dollar market.

As DICK'S Sporting Goods preps its Q4 report, all eyes are on the costly Foot Locker integration and whether its core business can offset the drag.

A European company with Big Pharma roots brings its natural allergy aid, SnizIQ, to California, tapping into a growing demand for alternatives.

For the 14th straight year, Herzing University earns top U.S. News rankings. Discover the model of support and career focus driving its sustained success.

The warehouse club operator signals robust confidence with a major dividend hike and plans for four new stores, pushing its stock to near-record highs.

As Dauch Corp, formerly American Axle, prepares its Q4 results, all eyes are on its powertrain-agnostic strategy and the integration of Dowlais Group.